MedicareCompareUSA Joins Partners Program of America’s Physician Groups
APG’s Roughly 360 Physician Groups And Their 170,000 Physicians Now Have Preferred Access to Highly Acclaimed MedicareOnDemand To Help Retain...
Healthcare
Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference
Visit Covalon at booth 425 at the Annual Association of Pediatric Hematology/Oncology Nurses Conference and Exhibit in Cleveland, Ohio to...
CANAQUEST Announces Award of European Cannabinoid Patent
EU Patent #19846183.2 - A NOVEL BOTANICAL AND TETRAHYDROCANNABINOL ("THC") FORMULATION FOR THE REDUCTION OF CANNABIS-INDUCED NEGATIVE NEUROPSYCHIATRIC SIDE-EFFECTSWe believe...
Alpha II, LLC Appoints Ashley Womack as Chief Financial Officer
TALLAHASSE, FL / ACCESSWIRE / September 19, 2023 / Alpha II, LLC, a leading provider of revenue cycle management ("RCM")...
Ludwig Enterprises, Inc. Announces Marvin S. Hausman, M.D. as Chief Executive Officer
SPARKS, NV / ACCESSWIRE / September 19, 2023 / Ludwig (OTC:LUDG), a provider of innovative medical technologies, announced today Marvin...
Icario to Showcase Digital-First Healthcare Innovation at Three Key Industry Events in October
Health Action Leader to Have a Presence at HLTH 2023, MHPA23 and the NCQA Health Innovation SummitMINNEAPOLIS, Sept. 19, 2023...
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023...
HCA Healthcare Taps Nudj Health to Provide Remote Patient Monitoring Services to Patients
PASADENA, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Nudj Health, a tech-enabled health service that delivers evidence-based mental health and...
Elevar Therapeutics Joins Benefactors Council of Blue Faery, Leading Hepatocellular Carcinoma Advocacy Group
FORT LEE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and...
Revolutionary Partnership in Behavioral Health: Nabla Copilot and Opus EHR Join Forces to Enhance Clinical Practice with Powerful AI
MIAMI, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Nabla and Opus EHR, two trailblazing names in the healthcare technology sector, have...
Conduent’s BenefitWallet HSA Portfolio Moving to HealthEquity
FLORHAM PARK, N.J. and DRAPER, Utah, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a global technology-led business...
Parexel Appoints Gwyn Bebb, BM, BCh., Ph.D., to Lead Oncology Clinical Development
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need Parexel Gwyn Bebb, BM, BCh., Ph.D., Senior Vice...
Healthcare Triangle to Host Roundtable Discussion on Generative AI and Data Modernization Strategies for Healthcare
Key learnings include strategies and best practices for leveraging new technologies while maintaining data security, privacy, and compliancePLEASANTON, Calif., Sept....
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
Dedicated team of global regulatory experts delivers submissions in increasingly shorter timelinesPRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Certara,...
Rhythm Pharmaceuticals Receives Orphan Drug Designation from European Medicines Agency for Setmelanotide for Treatment of Acquired Hypothalamic Obesity
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the...
Icosavax to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023
SEATTLE, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP)...
BioVie to Participate in the Cantor Fitzgerald Global Healthcare Conference
CARSON CITY, Nev., Sept. 19, 2023 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company...
Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx(TM) for the Treatment of Acute Myocarditis
Recruitment Accelerating and Full Patient Enrollment Anticipated to be Completed During Q3 2024, up to Six Months Ahead of Schedule Multi-Center,...
Clarivate Unveils Citation Laureates 2023 – Annual List of Researchers of Nobel Class
71 Citation Laureates named by the Institute for Scientific Information have gone on to receive a Nobel Prize LONDON, Sept....
Poolbeg Pharma PLC Announces Immunomodulator I Patent Opposition Withdrawal
Important step in continued protection of Poolbeg's patent familyLONDON, UK / ACCESSWIRE / September 19, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF)...